Validian Corporation Announces Suite of Groundbreaking Secure Data-Exchange Solutions for Market Verticals
First solution meets crucial needs in healthcare industry
OTTAWA, Nov. 16 - Validian Corporation (BULLETIN BOARD: VLDI) , a leader in the research and development of innovative application-level security software and solutions for public and private enterprises, today announced that it is introducing a suite of secure data-exchange solutions. Validian's first solution, tailored for medical devices, pharmaceutical and bio-technology companies, enhances medical research by securing the exchange of sensitive research and trial data.
"The ability to capture and collect clinical research and product-performance data rapidly and efficiently is crucial for any organization engaged in research and development tests and trials," said Mike Demster, Vice President of Biomedical Business Development for the Memphis Regional Chamber. "Sending data electronically saves time and money, but the risks of theft, disclosure and subsequent prosecution or loss of critical trade secrets, accumulated investment in intellectual property and competitive advantage are huge. Validian's cost-effective software product secures the electronic exchange of research and test data, and provides significant advantage for any medical devices, pharmaceutical or bio-technology company."
By securing the electronic exchange of sensitive patient and product-performance data between physicians participating in research and trials and the research databases, Validian eliminates the risk of theft, compromise or accidental loss of patient health information (PHI), expedites the capture and collection of research and test data, and minimizes the risk of errors and information leaks.
"Validian has delivered a software product that provides complete security for sensitive PHI in transit, demonstrating once again that it's the technology leader when it comes to HIPAA compliance," said Bruce Benn, President and CEO of Validian Corporation. "Theft or premature disclosure of test and research data can result in prosecution under HIPAA. Industrial espionage, when valuable proprietary information is stolen and sold or given to competitors, can be equally as devastating with loss of competitive advantage, market share and stock price."
About Validian
Validian Corporation is a leader in the research and development of innovative application-security and secure data-exchange software and solutions for public and private enterprises. Validian ASI(TM) is a software-only development and deployment environment that enables secure data exchange to be integrated directly into applications rapidly and easily, lowering development costs. ASI protects against attacks by authenticating applications, and encrypting and decrypting data within applications to ensure data exchanged between trusted applications never travels in the clear. Secured by ASI, Validian Flash Communicator(TM) delivers protected file- and message-exchange capabilities among authenticated users. Cost-effective, simple-to-deploy and easy to manage, Validian solutions also facilitate security audit compliance. A U.S. corporation, Validian has offices in the United States, Canada and Switzerland.
Source: Validian Corporation
CONTACT: Nikki Sinclair of Validian, +1-613-230-7211, ext. 238, or nikki.sinclair@validian.com; or investors, Joe Zappulla of Wall Street Consultants Corp., +1-212-681-4100, or JZappulla@WallStreetIR.com, for Validian
Web site: http://www.validian.com/
